Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco

Updated on: January 03,2024

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco

Updated on:January 03,2024

Living close to urban green spaces is associated with decreased breast cancer risk

by Barcelona Institute for Global Health (ISGlobal)Credit: CC0 Public DomainAn increasing number of studies are reporting the health benefits of contact with urban green spaces. A new study from the B

Updated on: April 07,2024

Living close to urban green spaces is associated with decreased breast cancer risk

by Barcelona Institute for Global Health (ISGlobal)Credit: CC0 Public DomainAn increasing number of studies are reporting the health benefits of contact with urban green spaces. A new study from the B

Updated on:April 07,2024

Drug turns cancer gene into 'eat me' flag for immune system

by Robin Marks,University of California, San FranciscoMicroscopy of a lung tumor biopsy. Credit: Lin MaTumor cells are notoriously good at evading the human immune system; they put up physical w

Updated on: February 24,2024

Drug turns cancer gene into 'eat me' flag for immune system

by Robin Marks,University of California, San FranciscoMicroscopy of a lung tumor biopsy. Credit: Lin MaTumor cells are notoriously good at evading the human immune system; they put up physical w

Updated on:February 24,2024

Study suggests possible way to 'Smac' cancer

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainIn animals, a process of programmed cell death called apoptosis ensures cells die when they should. An opposing force, governed by

Updated on: January 30,2024

Study suggests possible way to 'Smac' cancer

by Dana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainIn animals, a process of programmed cell death called apoptosis ensures cells die when they should. An opposing force, governed by

Updated on:January 30,2024

Reversing chemotherapy resistance in pancreatic cancer

byStanford UniversityCredit: CC0 Public DomainPancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often resistant to chemotherapy. Now, researcher

Updated on: July 05,2024

Reversing chemotherapy resistance in pancreatic cancer

byStanford UniversityCredit: CC0 Public DomainPancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often resistant to chemotherapy. Now, researcher

Updated on:July 05,2024

Tumor-specific therapy targets ovarian cancer

by Anna Zarra Aldrich,University of ConnecticutUConn professor Xiuling Lu with members of her lab team at the School of Pharmacy on Nov. 8, 2018. Credit: (Sean Flynn/UConn Photo)Nami Therapeutic

Updated on: April 09,2024

Tumor-specific therapy targets ovarian cancer

by Anna Zarra Aldrich,University of ConnecticutUConn professor Xiuling Lu with members of her lab team at the School of Pharmacy on Nov. 8, 2018. Credit: (Sean Flynn/UConn Photo)Nami Therapeutic

Updated on:April 09,2024

Following the tumour DNA trail to crack the secrets of personalised medicine

by European Society for Medical OncologyCredit: CC0 Public DomainIndividualised therapies that target the specific genetic features of tumours have the potential to transform cancer diagnosis, tr

Updated on: April 01,2024

Following the tumour DNA trail to crack the secrets of personalised medicine

by European Society for Medical OncologyCredit: CC0 Public DomainIndividualised therapies that target the specific genetic features of tumours have the potential to transform cancer diagnosis, tr

Updated on:April 01,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024

Researchers develop tool that reduces errors in stem cell transplant reporting

by Children's Hospital of PhiladelphiaCredit: CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determinatio

Updated on: February 20,2024

Researchers develop tool that reduces errors in stem cell transplant reporting

by Children's Hospital of PhiladelphiaCredit: CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determinatio

Updated on:February 20,2024

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on: April 14,2024

New blood test developed to diagnose ovarian cancer

by Brigham and Women's HospitalIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epitheliu

Updated on:April 14,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on: September 10,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on:September 10,2024

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Updated on: March 30,2024

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Updated on:March 30,2024